{"id":"https://openalex.org/W7225410025","doi":"https://doi.org/10.21203/rs.3.rs-11425226/v1","title":"Serotonin reuptake inhibitors attenuate cardiac fibrosis in HFpEF by inhibiting the SERT-Hic5 pathway","display_name":"Serotonin reuptake inhibitors attenuate cardiac fibrosis in HFpEF by inhibiting the SERT-Hic5 pathway","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225410025","doi":"https://doi.org/10.21203/rs.3.rs-11425226/v1"},"language":"en","primary_location":{"id":"doi:10.21203/rs.3.rs-11425226/v1","doi":"https://doi.org/10.21203/rs.3.rs-11425226/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11425226/v1","pdf_url":"https://www.researchsquare.com/article/rs-11425226/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.researchsquare.com/article/rs-11425226/latest.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5145353594","display_name":"Mingyang Zhao","orcid":"https://orcid.org/0009-0008-3243-8679","observed_orcids":["https://orcid.org/0009-0008-3243-8679"]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Mingyang Zhao","raw_affiliation_strings":["Peking University Health Science Center"],"raw_orcid":"https://orcid.org/0009-0008-3243-8679","affiliations":[{"raw_affiliation_string":"Peking University Health Science Center","institution_ids":["https://openalex.org/I20231570"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5145353594"],"corresponding_institution_ids":["https://openalex.org/I20231570"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11083","display_name":"Cardiac Health and Mental Health","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heart-failure-with-preserved-ejection-fraction","display_name":"heart failure with preserved ejection fraction","score":0.890999972820282},{"id":"https://openalex.org/keywords/myocardial-fibrosis","display_name":"myocardial fibrosis","score":0.9869999885559082},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibitors","display_name":"serotonin reuptake inhibitors","score":0.9290000200271606},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.8650000095367432},{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.8270000219345093},{"id":"https://openalex.org/keywords/diastolic-dysfunction","display_name":"diastolic dysfunction","score":0.8500000238418579},{"id":"https://openalex.org/keywords/cardiac-remodeling","display_name":"cardiac remodeling","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hypertrophy","display_name":"hypertrophy","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8575000166893005},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.6146000027656555},{"id":"https://openalex.org/C2777420927","wikidata":"https://www.wikidata.org/wiki/Q5038318","display_name":"Cardiac fibrosis","level":3,"score":0.5845000147819519},{"id":"https://openalex.org/C57900726","wikidata":"https://www.wikidata.org/wiki/Q492905","display_name":"Diastole","level":3,"score":0.5784000158309937},{"id":"https://openalex.org/C3018763269","wikidata":"https://www.wikidata.org/wiki/Q5038318","display_name":"Myocardial fibrosis","level":3,"score":0.5640000104904175},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5063999891281128},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5047000050544739},{"id":"https://openalex.org/C3018791406","wikidata":"https://www.wikidata.org/wiki/Q945225","display_name":"Cardiac hypertrophy","level":3,"score":0.49630001187324524},{"id":"https://openalex.org/C2779177932","wikidata":"https://www.wikidata.org/wiki/Q907104","display_name":"Ranolazine","level":2,"score":0.45190000534057617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45010000467300415},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.4255000054836273},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39309999346733093},{"id":"https://openalex.org/C519536355","wikidata":"https://www.wikidata.org/wiki/Q21021151","display_name":"Repurposing","level":2,"score":0.37689998745918274},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.3564000129699707},{"id":"https://openalex.org/C2779537366","wikidata":"https://www.wikidata.org/wiki/Q7920323","display_name":"Ventricular remodeling","level":3,"score":0.3427000045776367},{"id":"https://openalex.org/C2777099384","wikidata":"https://www.wikidata.org/wiki/Q3799239","display_name":"Heart failure with preserved ejection fraction","level":4,"score":0.3257000148296356},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31520000100135803},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.2962000072002411},{"id":"https://openalex.org/C2776002628","wikidata":"https://www.wikidata.org/wiki/Q1628627","display_name":"Left ventricular hypertrophy","level":3,"score":0.29269999265670776},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.28769999742507935},{"id":"https://openalex.org/C2993469949","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Cardiac dysfunction","level":3,"score":0.2849000096321106},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.27709999680519104},{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.2743000090122223},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.258899986743927},{"id":"https://openalex.org/C207886595","wikidata":"https://www.wikidata.org/wiki/Q1456138","display_name":"Pathological","level":2,"score":0.2531000077724457}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21203/rs.3.rs-11425226/v1","doi":"https://doi.org/10.21203/rs.3.rs-11425226/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11425226/v1","pdf_url":"https://www.researchsquare.com/article/rs-11425226/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-11425226/v1","doi":"https://doi.org/10.21203/rs.3.rs-11425226/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11425226/v1","pdf_url":"https://www.researchsquare.com/article/rs-11425226/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225410025.pdf","grobid_xml":"https://content.openalex.org/works/W7225410025.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2413163679","https://openalex.org/W2074305473","https://openalex.org/W4389074559","https://openalex.org/W4225877535","https://openalex.org/W3012942127","https://openalex.org/W2626607827","https://openalex.org/W4310732505","https://openalex.org/W7171866680","https://openalex.org/W3214794984","https://openalex.org/W4389945033"],"abstract_inverted_index":{"Abstract":[0],"HFpEF":[1,49,54,82],"lacks":[2],"therapies":[3],"that":[4],"directly":[5],"reverse":[6,20],"cardiac":[7,21],"fibrosis.":[8],"We":[9],"used":[10],"cMAP":[11],"screening":[12],"to":[13,19,48],"identify":[14],"SSRIs":[15,75],"as":[16],"candidate":[17],"agents":[18],"remodeling.":[22],"In":[23,51],"two":[24],"independent":[25],"clinical":[26],"cohorts,":[27],"SSRI":[28],"exposure":[29],"was":[30],"associated":[31],"with":[32],"improved":[33],"diastolic":[34,58],"function,":[35],"attenuated":[36],"remodeling":[37],"and":[38,61,83],"reduced":[39],"multiorgan":[40],"dysfunction.":[41],"Human":[42],"myocardial":[43],"biopsies":[44],"linked":[45],"SERT-Hic5":[46],"signaling":[47],"severity.":[50],"a":[52],"murine":[53],"model,":[55],"fluvoxamine":[56],"ameliorated":[57],"dysfunction,":[59],"hypertrophy":[60],"fibrosis":[62],"by":[63],"inhibiting":[64],"fibroblast":[65],"SERT.":[66],"Our":[67],"findings":[68],"highlight":[69],"the":[70],"therapeutic":[71],"potential":[72],"of":[73],"repurposing":[74],"targeting":[76],"this":[77],"fibroblast-specific":[78],"pathogenic":[79],"cascade":[80],"for":[81],"support":[84],"further":[85],"prospective":[86],"investigation.":[87]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-07T00:00:00"}